Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significance

Elevated plasma matrix metalloproteinases and their tissue inhibitors in patients with severe sepsis

(2011) Payam Yazdan-Ashoori et al.   JOURNAL OF CRITICAL CARE

Serum MMP-8, -9 and TIMP-1 in sepsis: High serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines

(2011) Anneli Lauhio et al.   PHARMACOLOGICAL RESEARCH

The chromogranin A- derived N-terminal peptide vasostatin-I: In vivo effects on cardiovascular variables in the rabbit

(2011) Silvestro Roatta et al.   REGULATORY PEPTIDES

Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial

(2010) Helge Røsjø et al.   EUROPEAN JOURNAL OF HEART FAILURE

Catecholamines, cardiac natriuretic peptides and chromogranin A: evolution and physiopathology of a 'whip-brake' system of the endocrine heart

(2010) B. Tota et al.   JOURNAL OF EXPERIMENTAL BIOLOGY

Prognostic Value of Chromogranin A at Admission in Critically Ill Patients: A Cohort Study in a Medical Intensive Care Unit

(2008) D. Zhang et al.   CLINICAL CHEMISTRY

Does severe non-infectious SIRS differ from severe sepsis?

(2008) Joel M. Dulhunty et al.   INTENSIVE CARE MEDICINE